1-3 of 3
Martina Ulrike Muckenthaler
Close
Sort by
Journal Articles

The Favorable Effect of Activating NOTCH1 Receptor Mutations On Long Term Outcome in T-ALL Is Treatment Related and Can Be Separated From NOTCH Pathway Activation by FBXW7 Loss of Function.

Corinne Kox, Martin Zimmermann, PhD, Martin Stanulla, MD, Martin Schrappe, MD, Wolf-Dieter Ludwig, Rolf Koehler, PhD, Svenja Leible, Gabriele Tolle, Obul Reddy Bandapalli, Stephen Breit, Martina Ulrike Muckenthaler, Andreas Kulozik, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 908.
https://doi.org/10.1182/blood.V114.22.908.908
Published: 2009
Journal Articles

High-Resolution Genomic Profiling (array-CGH) of Childhood T-ALL Identifies Deletions at 6q15-16.1 as a Predictive Marker for Early Treatment Response.

Marc Remke, Stefan Pfister, Martin Stanulla, Martin Schrappe, Martina Ulrike Muckenthaler, Peter Lichter, Andreas Kulozik
Journal: Blood
Blood (2008) 112 (11): 1484.
https://doi.org/10.1182/blood.V112.11.1484.1484
Published: 2008
Journal Articles

Notch Pathway Activation by a Combination of Activating NOTCH1 -Receptor and Inactivating FBXW7 Mutations Robustly Predicts Excellent Early Treatment Response in Pediatric T-ALL.

Corinne Kox, Svenja Leible, Stephen Breit, Martin Stanulla, MD, Martin Schrappe, MD, Martina Ulrike Muckenthaler, Andreas Kulozik
Journal: Blood
Blood (2008) 112 (11): 1493.
https://doi.org/10.1182/blood.V112.11.1493.1493
Published: 2008